10/29/2024
6:40 PM | Nant Capital, LLC (Filed by)
Panbela Therapeutics (Subject)
| Form SC 13D | |
10/29/2024
6:38 PM | Nant Capital, LLC (Reporting)
Panbela Therapeutics (Issuer)
SOON-SHIONG PATRICK (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/29/2024
8:24 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:24 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:25 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:25 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:26 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
|
10/29/2024
8:26 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:27 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/28/2024
4:16 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:26 PM | Horvath Susan (Reporting)
Panbela Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
3:34 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
4:25 PM | Panbela Therapeutics (Filer)
| Form S-1/A | |
08/13/2024
7:39 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:40 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:42 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:43 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:45 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:46 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:47 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
4:08 PM | Panbela Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2024
4:30 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
07/30/2024
3:59 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
3:46 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
6:00 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
7:21 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
7:22 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
7:24 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
7:27 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
7:29 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
3:16 PM | Panbela Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
3:35 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
8:09 AM | Nasdaq Stock Market LLC (Filed by)
Panbela Therapeutics (Subject)
| Form 25-NSE | |
04/22/2024
7:02 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
3:31 PM | Panbela Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/17/2024
7:36 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
11:15 PM | Panbela Therapeutics (Filer)
| Form EFFECT | |
04/04/2024
3:17 PM | Panbela Therapeutics (Filer)
| Form DEF 14A | |
04/02/2024
11:15 PM | Panbela Therapeutics (Filer)
| Form EFFECT | |
03/29/2024
4:08 PM | Panbela Therapeutics (Filer)
| Form POS AM | |
03/29/2024
4:24 PM | Panbela Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |
03/26/2024
3:15 PM | Panbela Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
3:12 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
5:01 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
7:05 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
7:10 PM | Lind Global Fund II LP (Filed by)
Panbela Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024
4:24 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
6:15 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2024
4:28 PM | Panbela Therapeutics (Filer)
| Form 424B4 | |
01/29/2024
5:21 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2024
11:15 PM | Panbela Therapeutics (Filer)
| Form EFFECT | |
01/25/2024
11:22 AM | Panbela Therapeutics (Filer)
| Form S-1/A | |
01/25/2024
7:54 AM | Panbela Therapeutics (Filer)
| Form S-1/A | |
01/22/2024
5:08 AM | Panbela Therapeutics (Filer)
| Form S-1/A | |
01/19/2024
4:20 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
3:34 PM | Panbela Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/05/2024
11:48 AM | Panbela Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/21/2023
8:25 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2023
8:25 AM | Panbela Therapeutics (Filer)
| Form DEFA14A | |
12/20/2023
11:15 PM | Panbela Therapeutics (Filer)
| Form EFFECT | |
12/21/2023
5:00 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/24/2023
3:30 PM | Panbela Therapeutics (Filer)
| Form DEF 14A | |
11/13/2023
6:27 PM | GOLDMAN SACHS & CO. LLC (Reporting)
GOLDMAN SACHS GROUP INC (Reporting)
GOLDMAN SACHS GROUP INC (Reporting)
Panbela Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2023
6:29 PM | GOLDMAN SACHS & CO. LLC (Reporting)
GOLDMAN SACHS GROUP INC (Reporting)
GOLDMAN SACHS GROUP INC (Reporting)
Panbela Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
4:24 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
4:25 PM | Panbela Therapeutics (Filer)
| Form DEFA14A | |
